Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 6, 2012, Pages 790-796

  Bae, Hong Beom ^a,d   Zmijewski, Jaroslaw W ^a   Deshane, Jessy S ^b   Zhi, Degui ^c   Thompson, Lawrence C ^e   Peterson, Cynthia B ^e   Chaplin, David D ^b   Abraham, Edward ^f  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Chonnam National University Medical School   (South Korea)

^e UNIVERSITY OF TENNESSEE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Inflammation; Lung injury; Neutrophils; Vitronectin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; BETA4 INTEGRIN; BETA5 INTEGRIN; CASPASE 3; CASPASE 9; CYCLO(ARGINYLGLYCYLASPARTYLPHENYLALANYLVALINE); CYCLOPEPTIDE; IMMUNOGLOBULIN G; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VITRONECTIN;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN MOTIF; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; INTEGRINS; MICE; MICE, INBRED C57BL; NEUTROPHILS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; VITRONECTIN;

MUS;

EID: 84861773596     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0187OC     Document Type: Article

References (42)

1. Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 2010;236:28-40.
2. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, et al. Cyclindependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006;12:1056-1064. (Pubitemid 44353387)
3. Gilroy DW, Lawrence T, PerrettiM, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004;3:401-416. (Pubitemid 38618123)
4. Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:L1137-L1145. (Pubitemid 32009500)
5. Preissner KT, Jenne D. Vitronectin: a new molecular connection in haemostasis. Thromb Haemost 1991;66:189-194.
6. Tomasini BR, Mosher DF. Vitronectin. Prog Hemost Thromb 1991;10:269-305.
7. Singh B, Janardhan KS, Kanthan R. Expression of angiostatin, integrin alphavbeta3, and vitronectin in human lungs in sepsis. Exp Lung Res 2005;31:771-782. (Pubitemid 41831705)
8. Tsuruta Y, Park Y-J, Siegal GP, Liu G, Abraham E. Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol 2007;179:7079-7086.
9. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002;3:932-943. (Pubitemid 35477371)
10. Reuning U, Magdolen V, Hapke S, Schmitt M. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem 2003;384:1119-1131. (Pubitemid 37121185)
11. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990;343:170-173.
12. Park YJ, Liu G, Lorne EF, Zhao X, Wang J, Tsuruta Y, Zmijewski J, Abraham E. PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci USA 2008;105:11784-11789.
13. Yang Y, Friggeri A, Banerjee S, Bdeir K, Cines DB, Liu G, Abraham E. Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils. Am J Respir Crit Care Med 2010;182:1516-1523.
14. Schar CR, Blouse GE, Minor KH, Peterson CB. A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity. J Biol Chem 2008;283:10297-10309.
15. Thompson LC, Goswami S, Ginsberg DS, Day DE, Verhamme IM, Peterson CB. Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition. Protein Sci 2011;20:353-365.
16. Zmijewski JW, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G, Abraham E. Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am J Respir Crit Care Med 2009;179:694-704.
17. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997;27:1-20. (Pubitemid 27059777)
18. Zmijewski JW, Lorne E, Zhao X, Tsuruta Y, Sha Y, Liu G, Siegal GP, Abraham E. Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med 2008;178:168-179. (Pubitemid 351957775)
19. Gibson AD, Lamerdin JA, Zhuang P, Baburaj K, Serpersu EH, Peterson CB. Orientation of heparin-binding sites in native vitronectin: analyses of ligand binding to the primary glycosaminoglycan-binding site indicate that putative secondary sites are not functional. J Biol Chem 1999;274:6432-6442. (Pubitemid 29111058)
20. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 2010;11:23-36.
21. Rømer MU, Larsen L, Offenberg H, Brünner N, Lademann UA. Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposideinduced apoptosis through activation of the PI3K/Akt cell survival pathway. Neoplasia 2008;10:1083-1091.
22. Rossignol P, Anglès-Cano E, Lijnen HR. Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis. Thromb Haemost 2006;96:665-670. (Pubitemid 44782548)
23. Prager GW, Mihaly J, Brunner PM, Koshelnick Y, Hoyer-Hansen G, Binder BR. Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Blood 2009;113:1383-1390.
24. Zhao H, Ross FP, Teitelbaum SL. Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. Mol Endocrinol 2005;19:771-780. (Pubitemid 40349447)
25. Zhou X, Murphy FR, Gehdu N, Zhang J, Iredale JP, Benyon RC. Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 2004;279:23996-24006. (Pubitemid 38725258)
26. Xu J, Millard M, Ren X, Cox OT, Erdreich-Epstein A. c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin. Blood 2010;115:2709-2718.
27. Chatterjee S, Brite KH, Matsumura A. Induction of apoptosis of integrinexpressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides. Clin Cancer Res 2001;7:3006-3011. (Pubitemid 32963817)
28. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339:269-280.
29. Filep JG, El Kebir D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J Cell Biochem 2009;108:1039-1046.
30. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 1996;383:441-443. (Pubitemid 26330833)
31. Isik FF, Gibran NS, Jang YC, Sandell L, Schwartz SM. Vitronectin decreases microvascular endothelial cell apoptosis. J Cell Physiol 1998;175:149-155. (Pubitemid 28140671)
32. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 1999;5:1587-1594. (Pubitemid 29282968)
33. Saldanha-Gama RF, Moraes JA, Mariano-Oliveira A, Coelho AL, Walsh EM, Marcinkiewicz C, Barja-Fidalgo C. Alpha(9)beta(1) integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members. Biochim Biophys Acta 2010;1803:848-857.
34. Lane D, Goncharenko-Khaider N, Rancourt C, Piche A. Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation. Oncogene 2010;29:3519-3531.
35. Li P, Jayarama S, Ganesh L, Mordi D, Carr R, Kanteti P, Hay N, Prabhakar BS. Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4. J Biol Chem 2010;285:22713-22722.
36. Wu J, Peng L, McMahon GA, Lawrence DA, Fay WP. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia. Arterioscler Thromb Vasc Biol 2009;29:1565-1570.
37. Singh B, Su Y-C, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol 2010;78:545-560.
38. Chillakuri CR, Jones C,Mardon HJ. Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading. FEBS Lett 2010;584:3287-3291.
39. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31(4, Suppl)S195-S199. (Pubitemid 36458167)
40. Parsey MV, Tuder RM, Abraham E. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998;160:1007-1013. (Pubitemid 28049347)
41. Matute-Bello G, Liles WC, Radella F II, Steinberg KP, Ruzinski JT, Jonas M, Chi EY, Hudson LD, Martin TR. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;156:1969-1977. (Pubitemid 28011809)
42. Parsey MV, Kaneko D, Shenkar R, Abraham E. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: apoptosis and migration are independent of interleukin-1beta. Chest 1999;116(1 Suppl)67S-68S. (Pubitemid 29340215)